{"transactions":[{"id":1425902,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88094,"kind":"person","name":"Blotner Bernard","position":1,"cik":"0001966742","reported_name":"Blotner Bernard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-22T22:04:10.000Z","date":"2024-08-20","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of January 15, 2025 or the date of the Issuer's annual meeting of stockholders held in 2025, and (ii) 50% of the options will vest on the earlier of January 15, 2026 or the date of the Issuer's annual meeting of stockholders held in 2026."}],"balance_after":125000,"derivative":{"exercise_price":0.07,"expiration_date":"2034-08-20","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001493152-24-033622","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000149315224033622/ownership.xml","form_type":"4"}},{"id":1816965,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88094,"kind":"person","name":"Blotner Bernard","position":1,"cik":"0001966742","reported_name":"Blotner Bernard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-03T20:14:38.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2024 or January 15, 2024 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2025 or January 15, 2025."}],"balance_after":125000,"derivative":{"exercise_price":0.12,"expiration_date":"2033-08-01","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-23-044409","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919123044409/doc4.xml","form_type":"4"}},{"id":1942179,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88094,"kind":"person","name":"Blotner Bernard","position":1,"cik":"0001966742","reported_name":"Blotner Bernard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-22T21:55:38.000Z","date":"2023-03-21","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.1299,"value":1299.0,"ownership":{"direct":false,"nature":"By Blotner Family Trust 3/4/98"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Blotner is a trustee of the Blotner Family Trust 3/4/98 and has voting and dispositive power with respect to these shares"}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-23-020594","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919123020594/doc4.xml","form_type":"4"}}]}